Sectoral Asset Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Sectoral Asset Management’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,158,271	Closed	-$10.2M	–	80
2019 Q3	$10.2M	Sell	1,158,271 -498,900	-30%	-$4.71M	1.76%	24
2019 Q2	$15.3M	Sell	1,657,171 -102,000	-6%	-$769K	1.83%	18
2019 Q1	$11.3M	Hold	1,759,171	–	–	1.36%	27
2018 Q4	$16.6M	Buy	1,759,171 +110,399	+7%	+$1.66M	2.26%	13
2018 Q3	$33.2M	Buy	1,648,772 +335,667	+26%	+$8.77M	3.52%	5
2018 Q2	$38.3M	Buy	1,313,105 +184,886	+16%	+$5.71M	4.28%	4
2018 Q1	$33.6M	Buy	1,128,219 +273,918	+32%	+$8.83M	3.68%	3
2017 Q4	$27.5M	Buy	854,301 +252,801	+42%	+$8.26M	3.44%	8
2017 Q3	$20.9M	Buy	601,500 +11,541	+2%	+$371K	2.69%	13
2017 Q2	$17.6M	Buy	589,959 +511,259	+650%	+$14.7M	1.92%	25
2017 Q1	$2.35M	Buy	+78,700	New	+$2.01M	0.27%	48

Other funds holding LJPC

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sectoral Asset Management's LJPC Position: Q4 2019 in Review

Sectoral Asset Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2019, closing a stake of 1,158,271 shares — an estimated $10.2M sold.

Sectoral Asset Management first reported a position in LJPC in Q1 2017 and held it in 11 quarters. The position peaked at $38.3M in Q2 2018. 77 funds tracked by Wall St. Rank hold LJPC as of Q4 2019.

Sectoral Asset Management reported no remaining La Jolla Pharmaceutical Company position as of Q4 2019 after selling out during the quarter.
Sectoral Asset Management sold 1,158,271 La Jolla Pharmaceutical Company shares in Q4 2019, an estimated $10.2M.
Sectoral Asset Management first reported a position in La Jolla Pharmaceutical Company in Q1 2017 and held it in 11 quarters.
Sectoral Asset Management's La Jolla Pharmaceutical Company position peaked at $38.3M in Q2 2018.
77 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2019.

Based on Sectoral Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.